<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-09-27" modified="2020-10-07" version="151">
<accession>Q8TDQ0</accession>
<accession>B2RAY2</accession>
<accession>Q8WW60</accession>
<accession>Q96K94</accession>
<name>HAVR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Hepatitis A virus cellular receptor 2</fullName>
<shortName>HAVcr-2</shortName>
</recommendedName>
<alternativeName>
<fullName>T-cell immunoglobulin and mucin domain-containing protein 3</fullName>
<shortName>TIMD-3</shortName>
</alternativeName>
<alternativeName>
<fullName>T-cell immunoglobulin mucin receptor 3</fullName>
<shortName>TIM-3</shortName>
</alternativeName>
<alternativeName>
<fullName>T-cell membrane protein 3</fullName>
</alternativeName>
<cdAntigenName>CD366</cdAntigenName>
</protein>
<gene>
<name type="primary">HAVCR2</name>
<name type="synonym">TIM3</name>
<name type="synonym">TIMD3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="Nature" volume="415" first="536" last="541">
<title>Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.</title>
<authorList>
<person name="Monney L."/>
<person name="Sabatos C.A."/>
<person name="Gaglia J.L."/>
<person name="Ryu A."/>
<person name="Waldner H."/>
<person name="Chernova T."/>
<person name="Manning S."/>
<person name="Greenfield E.A."/>
<person name="Coyle A.J."/>
<person name="Sobel R.A."/>
<person name="Freeman G.J."/>
<person name="Kuchroo V.K."/>
</authorList>
<dbReference type="PubMed" id="11823861"/>
<dbReference type="DOI" id="10.1038/415536a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>VARIANT LEU-140</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="submission" date="2000-04" db="EMBL/GenBank/DDBJ databases">
<title>Novel human hepatitis A virus cellular receptor.</title>
<authorList>
<person name="Zhang W."/>
<person name="Wan T."/>
<person name="Li N."/>
<person name="Cao X."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-140</scope>
<scope>VARIANT SPTCL ILE-101</scope>
</reference>
<reference key="3">
<citation type="submission" date="2001-12" db="EMBL/GenBank/DDBJ databases">
<title>A homolog to human kidney injury molecule-1 is expressed in hepatoma cells.</title>
<authorList>
<person name="Kuehn E.W."/>
<person name="Ichimura T."/>
<person name="Bonventre J.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-140</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-140</scope>
<source>
<tissue>Embryo</tissue>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT LEU-140</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT LEU-140</scope>
<source>
<tissue>Lung</tissue>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Nat. Immunol." volume="4" first="1093" last="1101">
<title>Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.</title>
<authorList>
<person name="Sanchez-Fueyo A."/>
<person name="Tian J."/>
<person name="Picarella D."/>
<person name="Domenig C."/>
<person name="Zheng X.X."/>
<person name="Sabatos C.A."/>
<person name="Manlongat N."/>
<person name="Bender O."/>
<person name="Kamradt T."/>
<person name="Kuchroo V.K."/>
<person name="Gutierrez-Ramos J.-C."/>
<person name="Coyle A.J."/>
<person name="Strom T.B."/>
</authorList>
<dbReference type="PubMed" id="14556005"/>
<dbReference type="DOI" id="10.1038/ni987"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="1245" last="1252">
<title>The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.</title>
<authorList>
<person name="Zhu C."/>
<person name="Anderson A.C."/>
<person name="Schubart A."/>
<person name="Xiong H."/>
<person name="Imitola J."/>
<person name="Khoury S.J."/>
<person name="Zheng X.X."/>
<person name="Strom T.B."/>
<person name="Kuchroo V.K."/>
</authorList>
<dbReference type="PubMed" id="16286920"/>
<dbReference type="DOI" id="10.1038/ni1271"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR LGALS9</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="351" first="571" last="576">
<title>A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9.</title>
<authorList>
<person name="van de Weyer P.S."/>
<person name="Muehlfeit M."/>
<person name="Klose C."/>
<person name="Bonventre J.V."/>
<person name="Walz G."/>
<person name="Kuehn E.W."/>
</authorList>
<dbReference type="PubMed" id="17069754"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.10.079"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-265</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Science" volume="318" first="1141" last="1143">
<title>Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.</title>
<authorList>
<person name="Anderson A.C."/>
<person name="Anderson D.E."/>
<person name="Bregoli L."/>
<person name="Hastings W.D."/>
<person name="Kassam N."/>
<person name="Lei C."/>
<person name="Chandwaskar R."/>
<person name="Karman J."/>
<person name="Su E.W."/>
<person name="Hirashima M."/>
<person name="Bruce J.N."/>
<person name="Kane L.P."/>
<person name="Kuchroo V.K."/>
<person name="Hafler D.A."/>
</authorList>
<dbReference type="PubMed" id="18006747"/>
<dbReference type="DOI" id="10.1126/science.1148536"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="J. Exp. Med." volume="205" first="2763" last="2779">
<title>Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.</title>
<authorList>
<person name="Jones R.B."/>
<person name="Ndhlovu L.C."/>
<person name="Barbour J.D."/>
<person name="Sheth P.M."/>
<person name="Jha A.R."/>
<person name="Long B.R."/>
<person name="Wong J.C."/>
<person name="Satkunarajah M."/>
<person name="Schweneker M."/>
<person name="Chapman J.M."/>
<person name="Gyenes G."/>
<person name="Vali B."/>
<person name="Hyrcza M.D."/>
<person name="Yue F.Y."/>
<person name="Kovacs C."/>
<person name="Sassi A."/>
<person name="Loutfy M."/>
<person name="Halpenny R."/>
<person name="Persad D."/>
<person name="Spotts G."/>
<person name="Hecht F.M."/>
<person name="Chun T.W."/>
<person name="McCune J.M."/>
<person name="Kaul R."/>
<person name="Rini J.M."/>
<person name="Nixon D.F."/>
<person name="Ostrowski M.A."/>
</authorList>
<dbReference type="PubMed" id="19001139"/>
<dbReference type="DOI" id="10.1084/jem.20081398"/>
</citation>
<scope>INVOLVEMENT IN T-CELL EXHAUSTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="9122" last="9130">
<title>Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.</title>
<authorList>
<person name="Golden-Mason L."/>
<person name="Palmer B.E."/>
<person name="Kassam N."/>
<person name="Townshend-Bulson L."/>
<person name="Livingston S."/>
<person name="McMahon B.J."/>
<person name="Castelblanco N."/>
<person name="Kuchroo V."/>
<person name="Gretch D.R."/>
<person name="Rosen H.R."/>
</authorList>
<dbReference type="PubMed" id="19587053"/>
<dbReference type="DOI" id="10.1128/jvi.00639-09"/>
</citation>
<scope>INVOLVEMENT IN T-CELL EXHAUSTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="J. Immunol." volume="184" first="1918" last="1930">
<title>T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells.</title>
<authorList>
<person name="DeKruyff R.H."/>
<person name="Bu X."/>
<person name="Ballesteros A."/>
<person name="Santpiago C."/>
<person name="Chim Y.L."/>
<person name="Lee H.H."/>
<person name="Karisola P."/>
<person name="Pichavant M."/>
<person name="Kaplan G.G."/>
<person name="Umetsu D.T."/>
<person name="Freeman G.J."/>
<person name="Casasnovas J.M."/>
</authorList>
<dbReference type="PubMed" id="20083673"/>
<dbReference type="DOI" id="10.4049/jimmunol.0903059"/>
</citation>
<scope>PHOSPHATIDYLSERINE-BINDING</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="1" last="17">
<title>Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD.</title>
<authorList>
<person name="Halim A."/>
<person name="Nilsson J."/>
<person name="Ruetschi U."/>
<person name="Hesse C."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="22171320"/>
<dbReference type="DOI" id="10.1074/mcp.m111.013649"/>
</citation>
<scope>GLYCOSYLATION AT THR-145</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Blood" volume="119" first="3064" last="3072">
<title>Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.</title>
<authorList>
<person name="Gleason M.K."/>
<person name="Lenvik T.R."/>
<person name="McCullar V."/>
<person name="Felices M."/>
<person name="O'Brien M.S."/>
<person name="Cooley S.A."/>
<person name="Verneris M.R."/>
<person name="Cichocki F."/>
<person name="Holman C.J."/>
<person name="Panoskaltsis-Mortari A."/>
<person name="Niki T."/>
<person name="Hirashima M."/>
<person name="Blazar B.R."/>
<person name="Miller J.S."/>
</authorList>
<dbReference type="PubMed" id="22323453"/>
<dbReference type="DOI" id="10.1182/blood-2011-06-360321"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Blood" volume="119" first="3734" last="3743">
<title>Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.</title>
<authorList>
<person name="Ndhlovu L.C."/>
<person name="Lopez-Verges S."/>
<person name="Barbour J.D."/>
<person name="Jones R.B."/>
<person name="Jha A.R."/>
<person name="Long B.R."/>
<person name="Schoeffler E.C."/>
<person name="Fujita T."/>
<person name="Nixon D.F."/>
<person name="Lanier L.L."/>
</authorList>
<dbReference type="PubMed" id="22383801"/>
<dbReference type="DOI" id="10.1182/blood-2011-11-392951"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="PLoS Pathog." volume="9" first="E1003253" last="E1003253">
<title>TIM-3 does not act as a receptor for galectin-9.</title>
<authorList>
<person name="Leitner J."/>
<person name="Rieger A."/>
<person name="Pickl W.F."/>
<person name="Zlabinger G."/>
<person name="Grabmeier-Pfistershammer K."/>
<person name="Steinberger P."/>
</authorList>
<dbReference type="PubMed" id="23555261"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1003253"/>
</citation>
<scope>FUNCTION AS A RECEPTOR FOR LGALS9</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="Eur. J. Immunol." volume="44" first="2703" last="2711">
<title>Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.</title>
<authorList>
<person name="Gautron A.S."/>
<person name="Dominguez-Villar M."/>
<person name="de Marcken M."/>
<person name="Hafler D.A."/>
</authorList>
<dbReference type="PubMed" id="24838857"/>
<dbReference type="DOI" id="10.1002/eji.201344392"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Immunol. Res." volume="59" first="56" last="65">
<title>Regulation of T cell responses by the receptor molecule Tim-3.</title>
<authorList>
<person name="Gorman J.V."/>
<person name="Colgan J.D."/>
</authorList>
<dbReference type="PubMed" id="24825777"/>
<dbReference type="DOI" id="10.1007/s12026-014-8524-1"/>
</citation>
<scope>REVIEW ON FUNCTION IN REGULATING T-CELL RESPONSES</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Immunol." volume="192" first="782" last="791">
<title>T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases.</title>
<authorList>
<person name="Clayton K.L."/>
<person name="Haaland M.S."/>
<person name="Douglas-Vail M.B."/>
<person name="Mujib S."/>
<person name="Chew G.M."/>
<person name="Ndhlovu L.C."/>
<person name="Ostrowski M.A."/>
</authorList>
<dbReference type="PubMed" id="24337741"/>
<dbReference type="DOI" id="10.4049/jimmunol.1302663"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH LGALS9 AND LCK</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0140694" last="E0140694">
<title>TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.</title>
<authorList>
<person name="Tomkowicz B."/>
<person name="Walsh E."/>
<person name="Cotty A."/>
<person name="Verona R."/>
<person name="Sabins N."/>
<person name="Kaplan F."/>
<person name="Santulli-Marotto S."/>
<person name="Chin C.N."/>
<person name="Mooney J."/>
<person name="Lingham R.B."/>
<person name="Naso M."/>
<person name="McCabe T."/>
</authorList>
<dbReference type="PubMed" id="26492563"/>
<dbReference type="DOI" id="10.1371/journal.pone.0140694"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH VAV1; AKT; LCP2; ZAP70; SYK; PIK3R1; FYN; SH3BP2 AND SH2D2A</scope>
<scope>MUTAGENESIS OF TYR-265 AND TYR-272</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2018" name="Nat. Genet." volume="50" first="1650" last="1657">
<title>Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.</title>
<authorList>
<person name="Gayden T."/>
<person name="Sepulveda F.E."/>
<person name="Khuong-Quang D.A."/>
<person name="Pratt J."/>
<person name="Valera E.T."/>
<person name="Garrigue A."/>
<person name="Kelso S."/>
<person name="Sicheri F."/>
<person name="Mikael L.G."/>
<person name="Hamel N."/>
<person name="Bajic A."/>
<person name="Dali R."/>
<person name="Deshmukh S."/>
<person name="Dervovic D."/>
<person name="Schramek D."/>
<person name="Guerin F."/>
<person name="Taipale M."/>
<person name="Nikbakht H."/>
<person name="Majewski J."/>
<person name="Moshous D."/>
<person name="Charlebois J."/>
<person name="Abish S."/>
<person name="Bole-Feysot C."/>
<person name="Nitschke P."/>
<person name="Bader-Meunier B."/>
<person name="Mitchell D."/>
<person name="Thieblemont C."/>
<person name="Battistella M."/>
<person name="Gravel S."/>
<person name="Nguyen V.H."/>
<person name="Conyers R."/>
<person name="Diana J.S."/>
<person name="McCormack C."/>
<person name="Prince H.M."/>
<person name="Besnard M."/>
<person name="Blanche S."/>
<person name="Ekert P.G."/>
<person name="Fraitag S."/>
<person name="Foulkes W.D."/>
<person name="Fischer A."/>
<person name="Neven B."/>
<person name="Michonneau D."/>
<person name="de Saint Basile G."/>
<person name="Jabado N."/>
</authorList>
<dbReference type="PubMed" id="30374066"/>
<dbReference type="DOI" id="10.1038/s41588-018-0251-4"/>
</citation>
<scope>INVOLVEMENT IN SPTCL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS SPTCL CYS-82 AND MET-97</scope>
<scope>CHARACTERIZATION OF VARIANTS SPTCL CYS-82 AND MET-97</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2019" name="Nat. Genet." volume="51" first="196" last="196">
<authorList>
<person name="Gayden T."/>
<person name="Sepulveda F.E."/>
<person name="Khuong-Quang D.A."/>
<person name="Pratt J."/>
<person name="Valera E.T."/>
<person name="Garrigue A."/>
<person name="Kelso S."/>
<person name="Sicheri F."/>
<person name="Mikael L.G."/>
<person name="Hamel N."/>
<person name="Bajic A."/>
<person name="Dali R."/>
<person name="Deshmukh S."/>
<person name="Dervovic D."/>
<person name="Schramek D."/>
<person name="Guerin F."/>
<person name="Taipale M."/>
<person name="Nikbakht H."/>
<person name="Majewski J."/>
<person name="Moshous D."/>
<person name="Charlebois J."/>
<person name="Abish S."/>
<person name="Bole-Feysot C."/>
<person name="Nitschke P."/>
<person name="Bader-Meunier B."/>
<person name="Mitchell D."/>
<person name="Thieblemont C."/>
<person name="Battistella M."/>
<person name="Gravel S."/>
<person name="Nguyen V.H."/>
<person name="Conyers R."/>
<person name="Diana J.S."/>
<person name="McCormack C."/>
<person name="Prince H.M."/>
<person name="Besnard M."/>
<person name="Blanche S."/>
<person name="Ekert P.G."/>
<person name="Fraitag S."/>
<person name="Foulkes W.D."/>
<person name="Fischer A."/>
<person name="Neven B."/>
<person name="Michonneau D."/>
<person name="de Saint Basile G."/>
<person name="Jabado N."/>
</authorList>
<dbReference type="PubMed" id="30429576"/>
<dbReference type="DOI" id="10.1038/s41588-018-0304-8"/>
</citation>
<scope>ERRATUM OF PUBMED:30374066</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2019" name="Blood Adv." volume="3" first="588" last="595">
<title>Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.</title>
<authorList>
<person name="Polprasert C."/>
<person name="Takeuchi Y."/>
<person name="Kakiuchi N."/>
<person name="Yoshida K."/>
<person name="Assanasen T."/>
<person name="Sitthi W."/>
<person name="Bunworasate U."/>
<person name="Pirunsarn A."/>
<person name="Wudhikarn K."/>
<person name="Lawasut P."/>
<person name="Uaprasert N."/>
<person name="Kongkiatkamon S."/>
<person name="Moonla C."/>
<person name="Sanada M."/>
<person name="Akita N."/>
<person name="Takeda J."/>
<person name="Fujii Y."/>
<person name="Suzuki H."/>
<person name="Nannya Y."/>
<person name="Shiraishi Y."/>
<person name="Chiba K."/>
<person name="Tanaka H."/>
<person name="Miyano S."/>
<person name="Rojnuckarin P."/>
<person name="Ogawa S."/>
<person name="Makishima H."/>
</authorList>
<dbReference type="PubMed" id="30792187"/>
<dbReference type="DOI" id="10.1182/bloodadvances.2018028340"/>
</citation>
<scope>INVOLVEMENT IN SPTCL</scope>
<scope>VARIANTS SPTCL CYS-82 AND ILE-101</scope>
</reference>
<comment type="function">
<text evidence="3 6 7 10 16 18 20 21 22 29">Cell surface receptor implicated in modulating innate and adaptive immune responses. Generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand (PubMed:24825777). Regulates macrophage activation (PubMed:11823861). Inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance (PubMed:14556005). In CD8+ cells attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. The function may implicate its association with LCK proposed to impair phosphorylation of TCR subunits, and/or LGALS9-dependent recruitment of PTPRC to the immunological synapse (PubMed:24337741, PubMed:26492563). In contrast, shown to activate TCR-induced signaling in T-cells probably implicating ZAP70, LCP2, LCK and FYN (By similarity). Expressed on Treg cells can inhibit Th17 cell responses (PubMed:24838857). Receptor for LGALS9 (PubMed:16286920, PubMed:24337741). Binding to LGALS9 is believed to result in suppression of T-cell responses; the resulting apoptosis of antigen-specific cells may implicate HAVCR2 phosphorylation and disruption of its association with BAG6. Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens. Expressed on Th1 cells interacts with LGALS9 expressed on Mycobacterium tuberculosis-infected macrophages to stimulate antibactericidal activity including IL-1 beta secretion and to restrict intracellular bacterial growth (By similarity). However, the function as receptor for LGALS9 has been challenged (PubMed:23555261). Also reported to enhance CD8+ T-cell responses to an acute infection such as by Listeria monocytogenes (By similarity). Receptor for phosphatidylserine (PtSer); PtSer-binding is calcium-dependent. May recognize PtSer on apoptotic cells leading to their phagocytosis. Mediates the engulfment of apoptotic cells by dendritic cells. Expressed on T-cells, promotes conjugation but not engulfment of apoptotic cells. Expressed on dendritic cells (DCs) positively regulates innate immune response and in synergy with Toll-like receptors promotes secretion of TNF-alpha. In tumor-imfiltrating DCs suppresses nucleic acid-mediated innate immune repsonse by interaction with HMGB1 and interfering with nucleic acid-sensing and trafficking of nucleid acids to endosomes (By similarity). Expressed on natural killer (NK) cells acts as a coreceptor to enhance IFN-gamma production in response to LGALS9 (PubMed:22323453). In contrast, shown to suppress NK cell-mediated cytotoxicity (PubMed:22383801). Negatively regulates NK cell function in LPS-induced endotoxic shock (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3 19 21">Interacts with HMGB1; impairs HMGB1 binding to B-DNA and likely HMGB1-mediated innate immune response (By similarity). Interacts with BAG6 (By similarity). Interacts (phosphorylated) with PIK3R1 and PIK3R2. Interacts (not dependent on its phosphorylation status) with FYN (By similarity). Interacts (in basal state T-cells) with VAV1; AKT1/2, LCP2, ZAP70, SYK, PIK3R1, FYN, SH3BP2 and SH2D2A. Interacts (in activated T-cells) with LCK and PLCG (PubMed:26492563, PubMed:24337741).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11472922">
<id>Q8TDQ0</id>
</interactant>
<interactant intactId="EBI-4314481">
<id>P13688</id>
<label>CEACAM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11472922">
<id>Q8TDQ0</id>
</interactant>
<interactant intactId="EBI-8652744">
<id>Q96IW7</id>
<label>SEC22A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11472922">
<id>Q8TDQ0</id>
</interactant>
<interactant intactId="EBI-12015604">
<id>Q8N2M4</id>
<label>TMEM86A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="28">Membrane</location>
<topology evidence="28">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22">Cell membrane</location>
</subcellularLocation>
<text evidence="19">Localizes to the immunological synapse between CD8+ T-cells and target cells.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8TDQ0-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8TDQ0-2</id>
<name>2</name>
<sequence type="described" ref="VSP_017287 VSP_017288"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="6 11 12 13 14 16 17 20">Expressed in T-helper type 1 (Th1) lymphocytes. Expressed on regulatory T (Treg) cells after TCR stimulation. Expressed in dendritic cells and natural killer (NK) cells. Expressed in epithelial tissues. Expression is increased on CD4+ and CD8+ T-cells in chronic hepatitis C virus (HCV) infection. In progressive HIV-1 infection, expression is up-regulated on HIV-1-specific CD8 T-cells.</text>
</comment>
<comment type="PTM">
<text evidence="15">O-glycosylated with core 1 or possibly core 8 glycans.</text>
</comment>
<comment type="PTM">
<text evidence="3 11 19">Phosphorylated on tyrosine residues; modestly increased after TCR/CD28 stimulation. Can be phosphorylated in the cytoplasmatic domain by FYN (By similarity). Phosphorylation at Tyr-265 is increased by stimulation with ligand LGALS9.</text>
</comment>
<comment type="disease">
<text evidence="13 14">May be involved in T-cell exhaustion associated with chronic viral infections such as with human immunodeficiency virus (HIV) and hepatitic C virus (HCV).</text>
</comment>
<comment type="disease" evidence="22 23 24">
<disease id="DI-05542">
<name>T-cell lymphoma, subcutaneous panniculitis-like</name>
<acronym>SPTCL</acronym>
<description>An uncommon form of T-cell non-Hodgkin lymphoma, in which cytotoxic CD8+ T-cells infiltrate subcutaneous adipose tissue, and rimming adipocytes in a lace-like pattern. Affected individuals typically present with multiple subcutaneous nodules, systemic B-cell symptoms, and, in a subset of cases, autoimmune disorders, most commonly systemic lupus erythematosus. A subset of patients develop hemophagocytic lymphohistiocytosis. SPTCL transmission pattern is consistent with autosomal recessive inheritance with incomplete penetrance.</description>
<dbReference type="MIM" id="618398"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the immunoglobulin superfamily. TIM family.</text>
</comment>
<comment type="caution">
<text evidence="29">Experimental results based on the injection of HAVCR2/TIM-3 antibodies or use of HAVCR2/TIM-3-Fc fusion proteins can reflect changes in the activity of several cell types and pathways as HAVCR2/TIM-3 is expressed by multiple immune cell types.</text>
</comment>
<dbReference type="EMBL" id="AF251707">
<property type="protein sequence ID" value="AAM19100.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY069944">
<property type="protein sequence ID" value="AAL55401.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027334">
<property type="protein sequence ID" value="BAB55044.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314406">
<property type="protein sequence ID" value="BAG37029.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011377">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61614.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC020843">
<property type="protein sequence ID" value="AAH20843.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC063431">
<property type="protein sequence ID" value="AAH63431.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4333.1">
<molecule id="Q8TDQ0-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_116171.3">
<molecule id="Q8TDQ0-1"/>
<property type="nucleotide sequence ID" value="NM_032782.4"/>
</dbReference>
<dbReference type="PDB" id="5DZL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=22-126"/>
</dbReference>
<dbReference type="PDB" id="5F71">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=22-130"/>
</dbReference>
<dbReference type="PDB" id="6DHB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=24-130"/>
</dbReference>
<dbReference type="PDB" id="6TXZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A/B/C/D=22-130"/>
</dbReference>
<dbReference type="PDBsum" id="5DZL"/>
<dbReference type="PDBsum" id="5F71"/>
<dbReference type="PDBsum" id="6DHB"/>
<dbReference type="PDBsum" id="6TXZ"/>
<dbReference type="SMR" id="Q8TDQ0"/>
<dbReference type="BioGRID" id="124313">
<property type="interactions" value="74"/>
</dbReference>
<dbReference type="DIP" id="DIP-61459N"/>
<dbReference type="IntAct" id="Q8TDQ0">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000312002"/>
<dbReference type="GlyConnect" id="712">
<property type="glycosylation" value="1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q8TDQ0">
<property type="glycosylation" value="4 sites, 1 O-linked glycan (3 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q8TDQ0"/>
<dbReference type="PhosphoSitePlus" id="Q8TDQ0"/>
<dbReference type="UniCarbKB" id="Q8TDQ0"/>
<dbReference type="BioMuta" id="HAVCR2"/>
<dbReference type="DMDM" id="311033536"/>
<dbReference type="jPOST" id="Q8TDQ0"/>
<dbReference type="MassIVE" id="Q8TDQ0"/>
<dbReference type="PaxDb" id="Q8TDQ0"/>
<dbReference type="PeptideAtlas" id="Q8TDQ0"/>
<dbReference type="PRIDE" id="Q8TDQ0"/>
<dbReference type="ProteomicsDB" id="74319">
<molecule id="Q8TDQ0-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="74320">
<molecule id="Q8TDQ0-2"/>
</dbReference>
<dbReference type="ABCD" id="Q8TDQ0">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="2450">
<property type="antibodies" value="1229 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="84868"/>
<dbReference type="Ensembl" id="ENST00000307851">
<molecule id="Q8TDQ0-1"/>
<property type="protein sequence ID" value="ENSP00000312002"/>
<property type="gene ID" value="ENSG00000135077"/>
</dbReference>
<dbReference type="GeneID" id="84868"/>
<dbReference type="KEGG" id="hsa:84868"/>
<dbReference type="UCSC" id="uc003lwk.3">
<molecule id="Q8TDQ0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="84868"/>
<dbReference type="DisGeNET" id="84868"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000135077.8"/>
<dbReference type="GeneCards" id="HAVCR2"/>
<dbReference type="HGNC" id="HGNC:18437">
<property type="gene designation" value="HAVCR2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000135077">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="HAVCR2"/>
<dbReference type="MIM" id="606652">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618398">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8TDQ0"/>
<dbReference type="OpenTargets" id="ENSG00000135077"/>
<dbReference type="Orphanet" id="86884">
<property type="disease" value="Subcutaneous panniculitis-like T-cell lymphoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134883425"/>
<dbReference type="eggNOG" id="ENOG502S454">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154444"/>
<dbReference type="InParanoid" id="Q8TDQ0"/>
<dbReference type="KO" id="K20414"/>
<dbReference type="OMA" id="EHGPAET"/>
<dbReference type="OrthoDB" id="1147868at2759"/>
<dbReference type="PhylomeDB" id="Q8TDQ0"/>
<dbReference type="TreeFam" id="TF336163"/>
<dbReference type="PathwayCommons" id="Q8TDQ0"/>
<dbReference type="Reactome" id="R-HSA-451927">
<property type="pathway name" value="Interleukin-2 family signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="84868">
<property type="hits" value="3 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="HAVCR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="HAVCR2"/>
<dbReference type="GenomeRNAi" id="84868"/>
<dbReference type="Pharos" id="Q8TDQ0">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8TDQ0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q8TDQ0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000135077">
<property type="expression patterns" value="Expressed in layer of synovial tissue and 175 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8TDQ0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8TDQ0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001772">
<property type="term" value="C:immunological synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002281">
<property type="term" value="P:macrophage activation involved in immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060135">
<property type="term" value="P:maternal process involved in female pregnancy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002519">
<property type="term" value="P:natural killer cell tolerance induction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900425">
<property type="term" value="P:negative regulation of defense response to bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071656">
<property type="term" value="P:negative regulation of granulocyte colony-stimulating factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000521">
<property type="term" value="P:negative regulation of immunological synapse formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032687">
<property type="term" value="P:negative regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032703">
<property type="term" value="P:negative regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032712">
<property type="term" value="P:negative regulation of interleukin-3 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030886">
<property type="term" value="P:negative regulation of myeloid dendritic cell activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032815">
<property type="term" value="P:negative regulation of natural killer cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002859">
<property type="term" value="P:negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001189">
<property type="term" value="P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042130">
<property type="term" value="P:negative regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002826">
<property type="term" value="P:negative regulation of T-helper 1 type immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900426">
<property type="term" value="P:positive regulation of defense response to bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045089">
<property type="term" value="P:positive regulation of innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032732">
<property type="term" value="P:positive regulation of interleukin-1 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032753">
<property type="term" value="P:positive regulation of interleukin-4 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042102">
<property type="term" value="P:positive regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904469">
<property type="term" value="P:positive regulation of tumor necrosis factor secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002652">
<property type="term" value="P:regulation of tolerance induction dependent upon immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034138">
<property type="term" value="P:toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034154">
<property type="term" value="P:toll-like receptor 7 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034162">
<property type="term" value="P:toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR013106">
<property type="entry name" value="Ig_V-set"/>
</dbReference>
<dbReference type="Pfam" id="PF07686">
<property type="entry name" value="V-set"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Hepatitis A virus cellular receptor 2" id="PRO_0000042101">
<location>
<begin position="22"/>
<end position="301"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="22"/>
<end position="202"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="4">
<location>
<begin position="203"/>
<end position="223"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="224"/>
<end position="301"/>
</location>
</feature>
<feature type="domain" description="Ig-like V-type">
<location>
<begin position="22"/>
<end position="124"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="3">
<location>
<position position="116"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3">
<location>
<position position="119"/>
</location>
</feature>
<feature type="binding site" description="Phosphatidylserine" evidence="3">
<location>
<position position="111"/>
</location>
</feature>
<feature type="binding site" description="Phosphatidylserine; via amide nitrogen" evidence="3">
<location>
<position position="118"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ITK" evidence="11">
<location>
<position position="265"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="15">
<location>
<position position="145"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="172"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5">
<location>
<begin position="38"/>
<end position="110"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5">
<location>
<begin position="52"/>
<end position="63"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5">
<location>
<begin position="58"/>
<end position="109"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017287" evidence="27">
<original>AKVTPAPTRQR</original>
<variation>GEWTFACHLYE</variation>
<location>
<begin position="132"/>
<end position="142"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_017288" evidence="27">
<location>
<begin position="143"/>
<end position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In SPTCL; associated with disease susceptibility; results in dysregulated secretion of inflammatory cytokines by macrophages; affects protein folding; decreased localization at the cell membrane; dbSNP:rs184868814." id="VAR_082211" evidence="22 23">
<original>Y</original>
<variation>C</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In SPTCL; associated with disease susceptibility; affects protein folding; decreased localization at the cell membrane; dbSNP:rs35960726." id="VAR_082212" evidence="22">
<original>I</original>
<variation>M</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In SPTCL; may be associated with disease susceptibility; dbSNP:rs147827860." id="VAR_082213" evidence="23 24">
<original>T</original>
<variation>I</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1036199." id="VAR_025342" evidence="6 8 9 24 25 26">
<original>R</original>
<variation>L</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCR-induced NFAT activation; when associated with A-272." evidence="21">
<original>Y</original>
<variation>A</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on TCR-induced NFAT activation (phosphomimetic mutation); when associated with E-272." evidence="21">
<original>Y</original>
<variation>E</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TCR-induced NFAT activation; when associated with A-265." evidence="21">
<original>Y</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on TCR-induced NFAT activation (phosphomimetic mutation); when associated with E-265." evidence="21">
<original>Y</original>
<variation>E</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="24"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="51"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="60"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="64"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="82"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="106"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="115"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="121"/>
<end position="130"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F71"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6DHB"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8VIM0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11823861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14556005"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286920"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17069754"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18006747"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19001139"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19587053"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22171320"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22323453"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22383801"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23555261"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24337741"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24838857"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26492563"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30374066"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30792187"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="2"/>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24825777"/>
</source>
</evidence>
<sequence length="301" mass="33394" checksum="519A5B0D512B6173" modified="2010-11-02" version="3" precursor="true">MFSHLPFDCVLLLLLLLLTRSSEVEYRAEVGQNAYLPCFYTPAAPGNLVPVCWGKGACPVFECGNVVLRTDERDVNYWTSRYWLNGDFRKGDVSLTIENVTLADSGIYCCRIQIPGIMNDEKFNLKLVIKPAKVTPAPTRQRDFTAAFPRMLTTRGHGPAETQTLGSLPDINLTQISTLANELRDSRLANDLRDSGATIRIGIYIGAGICAGLALALIFGALIFKWYSHSKEKIQNLSLISLANLPPSGLANAVAEGIRSEENIYTIEENVYEVEEPNEYYCYVSSRQQPSQPLGCRFAMP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

